世界各国のリアルタイムなデータ・インテリジェンスで皆様をお手伝い

モノクローナル抗体診断試薬の世界市場:検査別分析(酵素結合免疫吸着法、二重抗原サンドイッチ化学発光法、アッセイ組換えイムノブロット法、ドット免疫金濾過アッセイ法)、用途別分析(腫瘍モニタリング、ウイルス検出、ホルモン診断、その他)、地域別規模・予測(COVID-19の影響分析付き)、2028年までの予測


Global Monoclonal Antibody Diagnostic Reagent Market: Analysis By Tests (Enzyme Linked Immunosorbent, Double Antigen Sandwich Chemiluminescence Method, Assay Recombinant Immunoblot and Dot-immunogold Filtration Assay), By Application (Tumor Monitoring, Virus Detection, Hormones Diagnosis and Others), By Region Size & Forecast with Impact Analysis of COVID-19 and Forecast up to 2028

モノクローナル抗体診断試薬は、モノクローナル抗体を活性成分として使用し、感染性病原体、異常細胞、または病気に対する身体の反応の一部を同定する試薬である。2022年、世界のモノクローナル抗体診断試薬市場... もっと見る

 

 

出版社 出版年月 電子版価格 ページ数 言語
Daedal Research
デダルリサーチ
2023年9月29日 US$2,250
シングルユーザライセンス(印刷不可)
ライセンス・価格情報・注文方法はこちら
141 英語

 

サマリー

モノクローナル抗体診断試薬は、モノクローナル抗体を活性成分として使用し、感染性病原体、異常細胞、または病気に対する身体の反応の一部を同定する試薬である。2022年、世界のモノクローナル抗体診断試薬市場は88.5億米ドルと評価され、2028年には186.3億米ドルに達する見込みである。

また、がん、自己免疫疾患、感染症など幅広い疾患の治療薬として、モノクローナル抗体治療薬の強力なパイプラインが開発されていることから、市場は今後さらに拡大すると予想される。さらに、モノクローナル抗体の合成と精製において著しい技術進歩が見られる。これにより、モノクローナル抗体診断試薬のコストと入手性が低下し、その用途も広がっている。モノクローナル抗体診断試薬の世界市場価値は、2023-2028年の予測期間中にCAGR 13.25%で成長すると予測されている。

市場細分化分析:

検査別報告書によると、世界のモノクローナル抗体診断試薬市場は4つの検査に区分される:酵素結合免疫吸着法(Enzyme Linked Immunosorbent)、二重抗原サンドイッチ化学発光法(Double Antigen Sandwich Chemiluminescence Method)、アッセイ組換えイムノブロット法(Assay Recombinant Immunoblot)、ドット免疫金濾過法(Dot-immunogold Filtration Assay)である。酵素結合免疫吸着法(Enzyme Linked Immunosorbent)は、生物学的サンプル中の特定のタンパク質、抗体、抗原、その他の化合物を同定するための一般的な生化学的手法であるため、2022年の市場シェアの大半を占めている。一方、同分野のCAGRが最も速いのは、がん、感染症、自己免疫疾患などの慢性疾患の有病率の増加によるもので、これらはELISA検査を使って診断・モニタリングできる。

用途別:報告書によると、世界のモノクローナル抗体診断試薬市場は4つの用途に区分される:腫瘍モニタリング、ウイルス検出、ホルモン診断、その他である。腫瘍マーカーを検出し、腫瘍を画像化し、腫瘍を標的として治療を行うことができるため、腫瘍モニタリング分野は2022年に市場の大半のシェアを獲得した。これは、がんの診断、治療、モニタリングの改善に役立つ。一方、ウイルス検出分野のCAGRが最も速いのは、モノクローナル抗体が標的抗原に対して特異性が高いため、ごく少量の抗原を検出するのに使用できるからである。ウイルスはしばしば体内で低レベルに存在するため、これはウイルス検出にとって重要である。

地域別本レポートでは、モノクローナル抗体診断試薬市場を地域別(北米、欧州、アジア太平洋地域、その他の地域)に分析している。北米のモノクローナル抗体診断試薬市場は、2022年に最も高い市場シェアを獲得した。これは、企業による研究開発費の増加や、政府によるがん研究への資金援助により、革新的なモノクローナル抗体治療法の開発が促進されたためである。

米国は、世界的に見ても最も医療支出が多い国のひとつである。このような医療インフラへの多額の投資が、モノクローナル抗体ベースの診断試薬を含む先進的な診断技術の採用を後押ししている。

さらに、アジア太平洋地域のモノクローナル抗体診断試薬は、同地域の政府や民間団体が医療に多額の投資を行っていることから、最も速いCAGRで成長すると予想されている。このため、新しい診断施設の開発や、モノクローナル抗体診断試薬のような新技術の採用が進んでいる。

モノクローナル抗体診断試薬の世界市場ダイナミクス:

成長の促進要因モノクローナル抗体診断試薬は、多くの癌の早期発見と正確な診断に役立つ。早期発見は、タイムリーな介入と救命治療の可能性を可能にするため、極めて重要である。モノクローナル抗体は特に、血液、組織、尿などの患者サンプルに含まれる癌関連抗原やバイオマーカーを標的とするように設計されている。さらに、高齢化、可処分所得の増加、医療費の増加、バイオテクノロジー企業への投資の増加、新規治療法を開発するための広範な研究開発努力などにより、市場の拡大が見込まれている。

課題市場の拡大は高コストによって阻害されると予測される。この価格設定の障壁は、アクセシビリティ、手頃な価格、持続可能性など、モノクローナル抗体ベースの診断薬の多くの分野に影響を及ぼす。モノクローナル抗体診断試薬は、一般的に他のタイプの診断試薬よりも高価である。モノクローナル抗体診断試薬市場が直面するその他の課題には、入手可能性の制限などがある。

トレンド世界のモノクローナル抗体診断試薬市場で見られる最も明確で広範なトレンドの1つは、ポイントオブケア検査(POCT)の利用可能性が高まっていることである。ポイント・オブ・ケア検査(POCT)により、診察室や診療所などの医療現場で患者を検査することが可能になる。これは患者にとって便利であり、患者の転帰を改善するのに役立つ。モノクローナル抗体診断試薬はPOCTアプリケーションに適しています。POCTはモノクローナル抗体診断試薬市場の重要なトレンドとして浮上している。予測期間中、モノクローナル抗体診断試薬市場のさらなる成長が見込まれるトレンドとしては、多重アッセイの利用拡大、技術進歩、モノクローナル抗体を用いた新しい治療法の開発などが挙げられる。

COVID-19の影響分析と今後の展望:

COVID-19の流行は、モノクローナル抗体診断試薬の発見、製造、使用に大きな影響を与えたため、世界市場にプラスの影響を与えた。COVID-19用にいくつかのモノクローナル抗体診断試薬が開発されている。これらの試薬は臨床試験で使用されており、近い将来、広く使用できるようになると期待されている。パンデミックによって、モノクローナル抗体診断試薬の研究開発への資金も増加している。COVID-19が市場に与える影響は長期に及ぶと思われる。

競争環境と最近の動向:

世界のモノクローナル抗体診断試薬市場は断片化されている。世界のモノクローナル抗体診断試薬市場の主要プレーヤーは以下の通り:

ベクトン・ディッキンソン・アンド・カンパニー(BDバイオサイエンス)
メルク社
キアゲン
バイオ・ラッド・ラボラトリーズ
アブカム社(バイオビジョン)
イノベント・バイオロジクス社
セルトリオン社
ユーロジェンテック(アナスペック)
バイオジェネックス
バイオケアメディカルLLC
アビバ・システム・バイオロジー
メディックス・バイオケミカ
クリエイティブ・ダイアグノスティックス
セル・シグナル・テクノロジー

主要企業は、この市場での競争力を維持するために、新製品の発売や新興市場への製品導入など、戦略的な取り組みに絶えず投資している。例えば、2022年1月、小野薬品工業株式会社(以下「小野薬品」という。神経変性疾患の新規治療標的に対するmAb医薬品の開発でNeuroimmune AGと提携した。


ページTOPに戻る


目次

1. Executive Summary

2. Introduction

2.1 Monoclonal Antibody Diagnostic Reagent: An Overview
2.1.1 Monoclonal Antibodies Used To Treat

2.2 Monoclonal Antibody Diagnostic Reagent Segmentation: An Overview
2.2.1 Monoclonal Antibody Diagnostic Reagent Segmentation

3. Global Market Analysis

3.1 Global Monoclonal Antibody Diagnostic Reagent Market: An Analysis

3.1.1 Global Monoclonal Antibody Diagnostic Reagent Market: An Overview
3.1.2 Global Monoclonal Antibody Diagnostic Reagent Market by Value
3.1.3 Global Monoclonal Antibody Diagnostic Reagent Market by Test (Enzyme Linked Immunosorbent, Double Antigen Sandwich Chemiluminescence Method, Assay Recombinant Immunoblot and Dot-immunogold Filtration Assay)
3.1.4 Global Monoclonal Antibody Diagnostic Reagent Market by Application (Tumor Monitoring, Virus Detection, Hormones Diagnosis and Others)
3.1.5 Global Monoclonal Antibody Diagnostic Reagent Market by Region (North America, Europe, Asia Pacific and Rest of the World)

3.2 Global Monoclonal Antibody Diagnostic Reagent Market: Tests Analysis

3.2.1 Global Monoclonal Antibody Diagnostic Reagent Market: Tests Overview
3.2.2 Global Enzyme Linked Immunosorbent Monoclonal Antibody Diagnostic Reagent Market by Value
3.2.3 Global Double Antigen Sandwich Chemiluminescence Method Monoclonal Antibody Diagnostic Reagent Market by Value
3.2.4 Global Assay Recombinant Immunoblot Monoclonal Antibody Diagnostic Reagent Market by Value
3.2.5 Global Dot-immunogold Filtration Assay Monoclonal Antibody Diagnostic Reagent Market by Value

3.3 Global Monoclonal Antibody Diagnostic Reagent Market: Application Analysis

3.3.1 Global Monoclonal Antibody Diagnostic Reagent Market: Application Overview
3.3.2 Global Tumor Monitoring Monoclonal Antibody Diagnostic Reagent Market by Value
3.3.3 Global Virus Detection Monoclonal Antibody Diagnostic Reagent Market by Value
3.3.4 Global Hormones Diagnosis Monoclonal Antibody Diagnostic Reagent Market by Value
3.3.5 Global Other Application Monoclonal Antibody Diagnostic Reagent Market by Value

4. Regional Market Analysis

4.1 North America Monoclonal Antibody Diagnostic Reagent Market: An Analysis

4.1.1 North America Monoclonal Antibody Diagnostic Reagent Market: An Overview
4.1.2 North America Monoclonal Antibody Diagnostic Reagent Market by Value
4.1.3 North America Monoclonal Antibody Diagnostic Reagent Market by Region (The US, Canada and Mexico)
4.1.4 The US Monoclonal Antibody Diagnostic Reagent Market by Value
4.1.5 Canada Monoclonal Antibody Diagnostic Reagent Market by Value
4.1.6 Mexico Monoclonal Antibody Diagnostic Reagent Market by Value

4.2 Europe Monoclonal Antibody Diagnostic Reagent Market: An Analysis

4.2.1 Europe Monoclonal Antibody Diagnostic Reagent Market: An Overview
4.2.2 Europe Monoclonal Antibody Diagnostic Reagent Market by Value
4.2.3 Europe Monoclonal Antibody Diagnostic Reagent Market by Region (Germany, UK, France, Italy, Spain, and Rest of Europe)
4.2.4 Germany Monoclonal Antibody Diagnostic Reagent Market by Value
4.2.5 UK Monoclonal Antibody Diagnostic Reagent Market by Value
4.2.6 France Monoclonal Antibody Diagnostic Reagent Market by Value
4.2.7 Italy Monoclonal Antibody Diagnostic Reagent Market by Value
4.2.8 Spain Monoclonal Antibody Diagnostic Reagent Market by Value
4.2.9 Rest of Europe Monoclonal Antibody Diagnostic Reagent Market by Value

4.3 Asia Pacific Monoclonal Antibody Diagnostic Reagent Market: An Analysis

4.3.1 Asia Pacific Monoclonal Antibody Diagnostic Reagent Market: An Overview
4.3.2 Asia Pacific Monoclonal Antibody Diagnostic Reagent Market by Value
4.3.3 Asia Pacific Monoclonal Antibody Diagnostic Reagent Market by Region (China, Japan, India, South Korea and Rest of Asia Pacific)
4.3.4 China Monoclonal Antibody Diagnostic Reagent Market by Value
4.3.5 Japan Monoclonal Antibody Diagnostic Reagent Market by Value
4.3.6 India Monoclonal Antibody Diagnostic Reagent Market by Value
4.3.7 South Korea Monoclonal Antibody Diagnostic Reagent Market by Value
4.3.8 Rest of Asia Pacific Monoclonal Antibody Diagnostic Reagent Market by Value

4.4 Rest of the World Monoclonal Antibody Diagnostic Reagent Market: An Analysis

4.4.1 Rest of the World Monoclonal Antibody Diagnostic Reagent Market: An Overview
4.4.2 Rest the World Monoclonal Antibody Diagnostic Reagent Market by Value

5. Impact of COVID-19

5.1 Impact of COVID-19
5.1.1 Impact of COVID-19 on Monoclonal Antibody Diagnostic Reagent
5.1.2 Post COVID-19 Impact

6. Market Dynamics

6.1 Growth Driver
6.1.1 Escalating Incidence of New Cancer Cases
6.1.2 Aging Population
6.1.3 Amplified Disposable Income
6.1.4 Growing Healthcare Expenditure
6.1.5 Growth in Investments in Biotech Companies
6.1.6 Extensive R&D Efforts to Develop Novel Therapies

6.2 Challenges
6.2.1 High Cost
6.2.2 Limited Availability

6.3 Market Trends
6.3.1 Increasing Availability of Point-of-care Testing (POCT)
6.3.2 Growing Use of Multiplexed Assays
6.3.3 Technological Advancements
6.3.4 Development Of New Monoclonal Antibody-based Therapies

7. Competitive Landscape

7.1 Global Monoclonal Antibody Diagnostic Reagent Market Players: Financial Comparison

8. Company Profiles

8.1 Becton, Dickinson and Company (BD Biosciences)
8.1.1 Business Overview
8.1.2 Operating Segments
8.1.3 Business Strategy

8.2 Merck & Co., Inc.
8.2.1 Business Overview
8.2.2 Operating Segments
8.2.3 Business Strategies

8.3 Qiagen
8.3.1 Business Overview
8.3.2 Operating Regions
8.3.3 Business Strategy

8.4 Bio-Rad Laboratories, Inc.
8.4.1 Business Overview
8.4.2 Operating Segments
8.4.3 Business Strategy

8.5 Abcam Plc., (BioVision)
8.5.1 Business Overview
8.5.2 Operating Regions
8.5.3 Business Strategy

8.6 Innovent Biologics, Inc.
8.6.1 Business Overview
8.6.2 Operating Regions
8.6.3 Business Strategy

8.7 Celltrion, Inc.
8.7.1 Business Overview
8.7.2 Operating Segments

8.8 Eurogentec (AnaSpec)
8.8.1 Business Overview
8.8.2 Business Strategy

8.9 BioGenex
8.9.1 Business Overview
8.9.2 Business Strategy

8.10 Biocare Medical LLC
8.10.1 Business Overview
8.10.2 Business Strategy

8.11 Aviva Systems Biology
8.11.1 Business Overview
8.11.2 Business Strategy

8.12 Medix Biochemica
8.12.1 Business Overview
8.12.2 Business Strategy

8.13 Creative Diagnostics
8.13.1 Business Overview

8.14 Cell Signaling Technology
8.14.1 Business Overview

List of Figures

Figure 1: Monoclonal Antibodies Used To Treat
Figure 2: Monoclonal Antibody Diagnostic Reagent Segmentation
Figure 3: Global Monoclonal Antibody Diagnostic Reagent Market by Value; 2018-2022 (US$ Billion)
Figure 4: Global Monoclonal Antibody Diagnostic Reagent Market by Value; 2023-2028 (US$ Billion)
Figure 5: Global Monoclonal Antibody Diagnostic Reagent Market by Test; 2022 (Percentage, %)
Figure 6: Global Monoclonal Antibody Diagnostic Reagent Market by Application; 2022 (Percentage, %)
Figure 7: Global Monoclonal Antibody Diagnostic Reagent Market by Region; 2022 (Percentage, %)
Figure 8: Global Enzyme Linked Immunosorbent Monoclonal Antibody Diagnostic Reagent Market by Value; 2018-2022 (US$ Billion)
Figure 9: Global Enzyme Linked Immunosorbent Monoclonal Antibody Diagnostic Reagent Market by Value; 2023-2028 (US$ Billion)
Figure 10: Global Double Antigen Sandwich Chemiluminescence Method Monoclonal Antibody Diagnostic Reagent Market by Value; 2018-2022 (US$ Billion)
Figure 11: Global Double Antigen Sandwich Chemiluminescence Method Monoclonal Antibody Diagnostic Reagent Market by Value; 2023-2028 (US$ Billion)
Figure 12: Global Assay Recombinant Immunoblot Monoclonal Antibody Diagnostic Reagent Market by Value; 2018-2022 (US$ Billion)
Figure 13: Global Assay Recombinant Immunoblot Monoclonal Antibody Diagnostic Reagent Market by Value; 2023-2028 (US$ Billion)
Figure 14: Global Dot-immunogold Filtration Assay Monoclonal Antibody Diagnostic Reagent Market by Value; 2018-2022 (US$ Million)
Figure 15: Global Dot-immunogold Filtration Assay Monoclonal Antibody Diagnostic Reagent Market by Value; 2023-2028 (US$ Billion)
Figure 16: Global Tumor Monitoring Monoclonal Antibody Diagnostic Reagent Market by Value; 2018-2022 (US$ Billion)
Figure 17: Global Tumor Monitoring Monoclonal Antibody Diagnostic Reagent Market by Value; 2023-2028 (US$ Billion)
Figure 18: Global Virus Detection Monoclonal Antibody Diagnostic Reagent Market by Value; 2018-2022 (US$ Billion)
Figure 19: Global Virus Detection Monoclonal Antibody Diagnostic Reagent Market by Value; 2023-2028 (US$ Billion)
Figure 20: Global Hormones Diagnosis Monoclonal Antibody Diagnostic Reagent Market by Value; 2018-2022 (US$ Billion)
Figure 21: Global Hormones Diagnosis Monoclonal Antibody Diagnostic Reagent Market by Value; 2023-2028 (US$ Billion)
Figure 22: Global Other Application Monoclonal Antibody Diagnostic Reagent Market by Value; 2018-2022 (US$ Billion)
Figure 23: Global Other Application Monoclonal Antibody Diagnostic Reagent Market by Value; 2023-2028 (US$ Billion)
Figure 24: North America Monoclonal Antibody Diagnostic Reagent Market by Value; 2018-2022 (US$ Billion)
Figure 25: North America Monoclonal Antibody Diagnostic Reagent Market by Value; 2023-2028 (US$ Billion)
Figure 26: North America Monoclonal Antibody Diagnostic Reagent Market by Region; 2022 (Percentage, %)
Figure 27: The US Monoclonal Antibody Diagnostic Reagent Market by Value; 2018-2022 (US$ Billion)
Figure 28: The US Monoclonal Antibody Diagnostic Reagent Market by Value; 2023-2028 (US$ Billion)
Figure 29: Canada Monoclonal Antibody Diagnostic Reagent Market by Value; 2018-2022 (US$ Million)
Figure 30: Canada Monoclonal Antibody Diagnostic Reagent Market by Value; 2023-2028 (US$ Million)
Figure 31: Mexico Monoclonal Antibody Diagnostic Reagent Market by Value; 2018-2022 (US$ Million)
Figure 32: Mexico Monoclonal Antibody Diagnostic Reagent Market by Value; 2023-2028 (US$ Million)
Figure 33: Europe Monoclonal Antibody Diagnostic Reagent Market by Value; 2018-2022 (US$ Billion)
Figure 34: Europe Monoclonal Antibody Diagnostic Reagent Market by Value; 2023-2028 (US$ Billion)
Figure 35: Europe Monoclonal Antibody Diagnostic Reagent Market by Region; 2022 (Percentage, %)
Figure 36: Germany Monoclonal Antibody Diagnostic Reagent Market by Value; 2018-2022 (US$ Million)
Figure 37: Germany Monoclonal Antibody Diagnostic Reagent Market by Value; 2023-2028 (US$ Million)
Figure 38: UK Monoclonal Antibody Diagnostic Reagent Market by Value; 2018-2022 (US$ Million)
Figure 39: UK Monoclonal Antibody Diagnostic Reagent Market by Value; 2023-2028 (US$ Million)
Figure 40: France Monoclonal Antibody Diagnostic Reagent Market by Value; 2018-2022 (US$ Million)
Figure 41: France Monoclonal Antibody Diagnostic Reagent Market by Value; 2023-2028 (US$ Million)
Figure 42: Italy Monoclonal Antibody Diagnostic Reagent Market by Value; 2018-2022 (US$ Million)
Figure 43: Italy Monoclonal Antibody Diagnostic Reagent Market by Value; 2023-2028 (US$ Million)
Figure 44: Spain Monoclonal Antibody Diagnostic Reagent Market by Value; 2018-2022 (US$ Million)
Figure 45: Spain Monoclonal Antibody Diagnostic Reagent Market by Value; 2023-2028 (US$ Million)
Figure 46: Rest of Europe Monoclonal Antibody Diagnostic Reagent Market by Value; 2018-2022 (US$ Million)
Figure 47: Rest of Europe Monoclonal Antibody Diagnostic Reagent Market by Value; 2023-2028 (US$ Billion)
Figure 48: Asia Pacific Monoclonal Antibody Diagnostic Reagent Market by Value; 2018-2022 (US$ Billion)
Figure 49: Asia Pacific Monoclonal Antibody Diagnostic Reagent Market by Value; 2023-2028 (US$ Billion)
Figure 50: Asia Pacific Monoclonal Antibody Diagnostic Reagent Market by Region; 2022 (Percentage, %)
Figure 51: China Monoclonal Antibody Diagnostic Reagent Market by Value; 2018-2022 (US$ Million)
Figure 52: China Monoclonal Antibody Diagnostic Reagent Market by Value; 2023-2028 (US$ Million)
Figure 53: Japan Monoclonal Antibody Diagnostic Reagent Market by Value; 2018-2022 (US$ Million)
Figure 54: Japan Monoclonal Antibody Diagnostic Reagent Market by Value; 2023-2028 (US$ Million)
Figure 55: India Monoclonal Antibody Diagnostic Reagent Market by Value; 2018-2022 (US$ Million)
Figure 56: India Monoclonal Antibody Diagnostic Reagent Market by Value; 2023-2028 (US$ Million)
Figure 57: South Korea Monoclonal Antibody Diagnostic Reagent Market by Value; 2018-2022 (US$ Million)
Figure 58: South Korea Monoclonal Antibody Diagnostic Reagent Market by Value; 2023-2028 (US$ Million)
Figure 59: Rest of Asia Pacific Monoclonal Antibody Diagnostic Reagent Market by Value; 2018-2022 (US$ Million)
Figure 60: Rest of Asia Pacific Monoclonal Antibody Diagnostic Reagent Market by Value; 2023-2028 (US$ Billion)
Figure 61: Rest of the World Monoclonal Antibody Diagnostic Reagent Market by Value; 2018-2022 (US$ Million)
Figure 62: Rest of the World Monoclonal Antibody Diagnostic Reagent Market by Value; 2023-2028 (US$ Billion)
Figure 63: The US Estimated Numbers of New Cancer Cases; 2017-2023 (Million)
Figure 64: Global Percentage of Population Aged 65 Years Or Over; 2022, 2030 & 2050 (Percentage, %)
Figure 65: Global GNI per Capita; 2016-2022 (Thousand)
Figure 66: The US Health Consumption Expenditure as a Percentage of GDP; 2016-2022 (Percentage, %)
Figure 67: Becton, Dickinson and Company Revenue by Segment; 2022 (Percentage, %)
Figure 68: Merck & Co., Inc. Sales by Segments; 2022 (Percentage, %)
Figure 69: Qiagen Net Sales by Regions; 2022 (Percentage, %)
Figure 70: Bio-Rad Laboratories, Inc. Net Sales by Segments; 2022 (Percentage, %)
Figure 71: Abcam Plc. Revenue by Regions; 2022 (Percentage, %)
Figure 72: Innovent Biologics, Inc. Revenue by Regions; 2022 (Percentage, %)
Figure 73: Celltrion, Inc. Revenue by Segments; 2022 (Percentage, %)
Table 1: Global Monoclonal Antibody Diagnostic Reagent Market Players: Financial Comparison; 2023

 

ページTOPに戻る


 

Summary

Monoclonal Antibody Diagnostic Reagents are reagents that use monoclonal antibodies as active components to identify infectious pathogens, aberrant cells, or parts of the body's reaction to sickness. In 2022, the global monoclonal antibody diagnostic reagent market was valued at US$8.85 billion, and is probable to reach US$18.63 billion by 2028.

The market is also expected to boost in the future as a robust pipeline of monoclonal antibody therapeutics is being developed for the treatment of a wide range of ailments, including cancer, autoimmune disorders, and infectious diseases. Furthermore, significant technological advances have been made in the synthesis and purification of monoclonal antibodies. This has reduced the cost and availability of monoclonal antibody diagnostic reagents while also broadening their applications. The global monoclonal antibody diagnostic reagent market value is projected to grow at a CAGR of 13.25%, during the forecast period of 2023-2028.

Market Segmentation Analysis:

By Tests: According to the report, the global monoclonal antibody diagnostic reagent market is segmented into four tests: Enzyme Linked Immunosorbent, Double Antigen Sandwich Chemiluminescence Method, Assay Recombinant Immunoblot and Dot-immunogold Filtration Assay. Enzyme Linked Immunosorbent segment acquired majority of share in the market in 2022, because this test is a popular biochemical technique for identifying specific proteins, antibodies, antigens, or other compounds in biological samples. Whereas, the same segment has the fastest CAGR due to the increasing prevalence of chronic diseases, such as cancer, infectious diseases, and autoimmune disorders, which can be diagnosed and monitored using ELISA tests.

By Application: According to the report, the global monoclonal antibody diagnostic reagent market is segmented into four applications: Tumor Monitoring, Virus Detection, Hormones Diagnosis and Others. Tumor Monitoring segment acquired majority of share in the market in 2022 as they can be used to detect tumor markers, image tumors, and target tumors for therapy. This can help to improve the diagnosis, treatment, and monitoring of cancer. Whereas, virus detection segment has the fastest CAGR because monoclonal antibodies are highly specific to their target antigens, which means that they can be used to detect very small amounts of the antigen. This is important for virus detection, as viruses are often present in low levels in the body.

By Region: The report provides insight into the monoclonal antibody diagnostic reagent market based on the geographical operations, namely North America, Europe, Asia Pacific, and Rest of the World. North America monoclonal antibody diagnostic reagent market enjoyed the highest market share in 2022, due to rising R&D spending by businesses and government funding for cancer research has facilitated the development of innovative monoclonal antibody treatments.

The US, has one of the highest healthcare spending rates globally. This substantial investment in healthcare infrastructure has driven the adoption of advanced diagnostic technologies, including monoclonal antibody-based diagnostic reagents.

Further, Asia Pacific monoclonal antibody diagnostic reagent is expected to grow at the fastest CAGR due to governments and private organizations in the region are investing heavily in healthcare. This is leading to the development of new diagnostic facilities and the adoption of new technologies, such as monoclonal antibody diagnostic reagents.

Global Monoclonal Antibody Diagnostic Reagent Market Dynamics:

Growth Drivers: Monoclonal antibody diagnostic reagents aid in the early identification and accurate diagnosis of many cancers. Early detection is crucial because it enables timely intervention and potentially life-saving therapy. Monoclonal antibodies are particularly designed to target cancer-related antigens or biomarkers found in patient samples such as blood, tissue, or urine. Further, the market is expected to increase due to aging population, amplified disposable income, growing healthcare expenditure, growth in investments in biotech companies, extensive R&D efforts to develop novel therapies, etc.

Challenges: The market's expansion is projected to be hampered by high cost. This pricing barrier affects many areas of monoclonal antibody-based diagnostics, including accessibility, affordability, and sustainability. Monoclonal antibody diagnostic reagents are typically more expensive than other types of diagnostic reagents. The other challenges that monoclonal antibody diagnostic reagent market faces include limited availability.

Trends: One of the most distinct and pervasive trends observed in the global monoclonal antibody diagnostic reagent market is increasing availability of point-of-care testing (POCT). Point-of-care testing (POCT) allows for the testing of patients at the point of care, such as in doctor's offices or clinics. This is convenient for patients and can help to improve patient outcomes. Monoclonal antibody diagnostic reagents are well-suited for POCT applications. POCT is emerging as a significant trend in the monoclonal antibody diagnostic reagent market. More trends in the market are believed to augment the growth of monoclonal antibody diagnostic reagent market during the forecasted period include, growing use of multiplexed assays, technological advancements and development of new monoclonal antibody-based therapies, etc.

Impact Analysis of COVID-19 and Way Forward:

The COVID-19 pandemic has a positive impact on the global market because the pandemic has had a significant impact on the discovery, manufacture, and use of monoclonal antibody diagnostic reagents. Several monoclonal antibody diagnostic reagents have been developed for COVID-19. These reagents are being used in clinical trials and are expected to be available for widespread use in the near future. The pandemic has also led to increased funding for research and development of monoclonal antibody diagnostic reagents. The impact of COVID-19 on the market is likely to be long-lasting.

Competitive Landscape and Recent Developments:

Global monoclonal antibody diagnostic reagent market is fragmented. Key players of global monoclonal antibody diagnostic reagent market are:

Becton, Dickinson and Company (BD Biosciences)
Merck & Co., Inc.
Qiagen
Bio-Rad Laboratories, Inc.
Abcam Plc., (BioVision)
Innovent Biologics, Inc.
Celltrion, Inc.
Eurogentec (AnaSpec)
BioGenex
Biocare Medical LLC
Aviva Systems Biology
Medix Biochemica
Creative Diagnostics
Cell Signaling Technology

The key players are constantly investing in strategic initiatives, such as new product launches, introducing their products to emerging markets and more, to maintain a competitive edge in this market. For instance, in January 2022, Ono Pharmaceutical Co., Ltd. Collaborated with Neuroimmune AG to develop the mAb drug against novel therapeutic targets for neurodegenerative diseases.



ページTOPに戻る


Table of Contents

1. Executive Summary

2. Introduction

2.1 Monoclonal Antibody Diagnostic Reagent: An Overview
2.1.1 Monoclonal Antibodies Used To Treat

2.2 Monoclonal Antibody Diagnostic Reagent Segmentation: An Overview
2.2.1 Monoclonal Antibody Diagnostic Reagent Segmentation

3. Global Market Analysis

3.1 Global Monoclonal Antibody Diagnostic Reagent Market: An Analysis

3.1.1 Global Monoclonal Antibody Diagnostic Reagent Market: An Overview
3.1.2 Global Monoclonal Antibody Diagnostic Reagent Market by Value
3.1.3 Global Monoclonal Antibody Diagnostic Reagent Market by Test (Enzyme Linked Immunosorbent, Double Antigen Sandwich Chemiluminescence Method, Assay Recombinant Immunoblot and Dot-immunogold Filtration Assay)
3.1.4 Global Monoclonal Antibody Diagnostic Reagent Market by Application (Tumor Monitoring, Virus Detection, Hormones Diagnosis and Others)
3.1.5 Global Monoclonal Antibody Diagnostic Reagent Market by Region (North America, Europe, Asia Pacific and Rest of the World)

3.2 Global Monoclonal Antibody Diagnostic Reagent Market: Tests Analysis

3.2.1 Global Monoclonal Antibody Diagnostic Reagent Market: Tests Overview
3.2.2 Global Enzyme Linked Immunosorbent Monoclonal Antibody Diagnostic Reagent Market by Value
3.2.3 Global Double Antigen Sandwich Chemiluminescence Method Monoclonal Antibody Diagnostic Reagent Market by Value
3.2.4 Global Assay Recombinant Immunoblot Monoclonal Antibody Diagnostic Reagent Market by Value
3.2.5 Global Dot-immunogold Filtration Assay Monoclonal Antibody Diagnostic Reagent Market by Value

3.3 Global Monoclonal Antibody Diagnostic Reagent Market: Application Analysis

3.3.1 Global Monoclonal Antibody Diagnostic Reagent Market: Application Overview
3.3.2 Global Tumor Monitoring Monoclonal Antibody Diagnostic Reagent Market by Value
3.3.3 Global Virus Detection Monoclonal Antibody Diagnostic Reagent Market by Value
3.3.4 Global Hormones Diagnosis Monoclonal Antibody Diagnostic Reagent Market by Value
3.3.5 Global Other Application Monoclonal Antibody Diagnostic Reagent Market by Value

4. Regional Market Analysis

4.1 North America Monoclonal Antibody Diagnostic Reagent Market: An Analysis

4.1.1 North America Monoclonal Antibody Diagnostic Reagent Market: An Overview
4.1.2 North America Monoclonal Antibody Diagnostic Reagent Market by Value
4.1.3 North America Monoclonal Antibody Diagnostic Reagent Market by Region (The US, Canada and Mexico)
4.1.4 The US Monoclonal Antibody Diagnostic Reagent Market by Value
4.1.5 Canada Monoclonal Antibody Diagnostic Reagent Market by Value
4.1.6 Mexico Monoclonal Antibody Diagnostic Reagent Market by Value

4.2 Europe Monoclonal Antibody Diagnostic Reagent Market: An Analysis

4.2.1 Europe Monoclonal Antibody Diagnostic Reagent Market: An Overview
4.2.2 Europe Monoclonal Antibody Diagnostic Reagent Market by Value
4.2.3 Europe Monoclonal Antibody Diagnostic Reagent Market by Region (Germany, UK, France, Italy, Spain, and Rest of Europe)
4.2.4 Germany Monoclonal Antibody Diagnostic Reagent Market by Value
4.2.5 UK Monoclonal Antibody Diagnostic Reagent Market by Value
4.2.6 France Monoclonal Antibody Diagnostic Reagent Market by Value
4.2.7 Italy Monoclonal Antibody Diagnostic Reagent Market by Value
4.2.8 Spain Monoclonal Antibody Diagnostic Reagent Market by Value
4.2.9 Rest of Europe Monoclonal Antibody Diagnostic Reagent Market by Value

4.3 Asia Pacific Monoclonal Antibody Diagnostic Reagent Market: An Analysis

4.3.1 Asia Pacific Monoclonal Antibody Diagnostic Reagent Market: An Overview
4.3.2 Asia Pacific Monoclonal Antibody Diagnostic Reagent Market by Value
4.3.3 Asia Pacific Monoclonal Antibody Diagnostic Reagent Market by Region (China, Japan, India, South Korea and Rest of Asia Pacific)
4.3.4 China Monoclonal Antibody Diagnostic Reagent Market by Value
4.3.5 Japan Monoclonal Antibody Diagnostic Reagent Market by Value
4.3.6 India Monoclonal Antibody Diagnostic Reagent Market by Value
4.3.7 South Korea Monoclonal Antibody Diagnostic Reagent Market by Value
4.3.8 Rest of Asia Pacific Monoclonal Antibody Diagnostic Reagent Market by Value

4.4 Rest of the World Monoclonal Antibody Diagnostic Reagent Market: An Analysis

4.4.1 Rest of the World Monoclonal Antibody Diagnostic Reagent Market: An Overview
4.4.2 Rest the World Monoclonal Antibody Diagnostic Reagent Market by Value

5. Impact of COVID-19

5.1 Impact of COVID-19
5.1.1 Impact of COVID-19 on Monoclonal Antibody Diagnostic Reagent
5.1.2 Post COVID-19 Impact

6. Market Dynamics

6.1 Growth Driver
6.1.1 Escalating Incidence of New Cancer Cases
6.1.2 Aging Population
6.1.3 Amplified Disposable Income
6.1.4 Growing Healthcare Expenditure
6.1.5 Growth in Investments in Biotech Companies
6.1.6 Extensive R&D Efforts to Develop Novel Therapies

6.2 Challenges
6.2.1 High Cost
6.2.2 Limited Availability

6.3 Market Trends
6.3.1 Increasing Availability of Point-of-care Testing (POCT)
6.3.2 Growing Use of Multiplexed Assays
6.3.3 Technological Advancements
6.3.4 Development Of New Monoclonal Antibody-based Therapies

7. Competitive Landscape

7.1 Global Monoclonal Antibody Diagnostic Reagent Market Players: Financial Comparison

8. Company Profiles

8.1 Becton, Dickinson and Company (BD Biosciences)
8.1.1 Business Overview
8.1.2 Operating Segments
8.1.3 Business Strategy

8.2 Merck & Co., Inc.
8.2.1 Business Overview
8.2.2 Operating Segments
8.2.3 Business Strategies

8.3 Qiagen
8.3.1 Business Overview
8.3.2 Operating Regions
8.3.3 Business Strategy

8.4 Bio-Rad Laboratories, Inc.
8.4.1 Business Overview
8.4.2 Operating Segments
8.4.3 Business Strategy

8.5 Abcam Plc., (BioVision)
8.5.1 Business Overview
8.5.2 Operating Regions
8.5.3 Business Strategy

8.6 Innovent Biologics, Inc.
8.6.1 Business Overview
8.6.2 Operating Regions
8.6.3 Business Strategy

8.7 Celltrion, Inc.
8.7.1 Business Overview
8.7.2 Operating Segments

8.8 Eurogentec (AnaSpec)
8.8.1 Business Overview
8.8.2 Business Strategy

8.9 BioGenex
8.9.1 Business Overview
8.9.2 Business Strategy

8.10 Biocare Medical LLC
8.10.1 Business Overview
8.10.2 Business Strategy

8.11 Aviva Systems Biology
8.11.1 Business Overview
8.11.2 Business Strategy

8.12 Medix Biochemica
8.12.1 Business Overview
8.12.2 Business Strategy

8.13 Creative Diagnostics
8.13.1 Business Overview

8.14 Cell Signaling Technology
8.14.1 Business Overview

List of Figures

Figure 1: Monoclonal Antibodies Used To Treat
Figure 2: Monoclonal Antibody Diagnostic Reagent Segmentation
Figure 3: Global Monoclonal Antibody Diagnostic Reagent Market by Value; 2018-2022 (US$ Billion)
Figure 4: Global Monoclonal Antibody Diagnostic Reagent Market by Value; 2023-2028 (US$ Billion)
Figure 5: Global Monoclonal Antibody Diagnostic Reagent Market by Test; 2022 (Percentage, %)
Figure 6: Global Monoclonal Antibody Diagnostic Reagent Market by Application; 2022 (Percentage, %)
Figure 7: Global Monoclonal Antibody Diagnostic Reagent Market by Region; 2022 (Percentage, %)
Figure 8: Global Enzyme Linked Immunosorbent Monoclonal Antibody Diagnostic Reagent Market by Value; 2018-2022 (US$ Billion)
Figure 9: Global Enzyme Linked Immunosorbent Monoclonal Antibody Diagnostic Reagent Market by Value; 2023-2028 (US$ Billion)
Figure 10: Global Double Antigen Sandwich Chemiluminescence Method Monoclonal Antibody Diagnostic Reagent Market by Value; 2018-2022 (US$ Billion)
Figure 11: Global Double Antigen Sandwich Chemiluminescence Method Monoclonal Antibody Diagnostic Reagent Market by Value; 2023-2028 (US$ Billion)
Figure 12: Global Assay Recombinant Immunoblot Monoclonal Antibody Diagnostic Reagent Market by Value; 2018-2022 (US$ Billion)
Figure 13: Global Assay Recombinant Immunoblot Monoclonal Antibody Diagnostic Reagent Market by Value; 2023-2028 (US$ Billion)
Figure 14: Global Dot-immunogold Filtration Assay Monoclonal Antibody Diagnostic Reagent Market by Value; 2018-2022 (US$ Million)
Figure 15: Global Dot-immunogold Filtration Assay Monoclonal Antibody Diagnostic Reagent Market by Value; 2023-2028 (US$ Billion)
Figure 16: Global Tumor Monitoring Monoclonal Antibody Diagnostic Reagent Market by Value; 2018-2022 (US$ Billion)
Figure 17: Global Tumor Monitoring Monoclonal Antibody Diagnostic Reagent Market by Value; 2023-2028 (US$ Billion)
Figure 18: Global Virus Detection Monoclonal Antibody Diagnostic Reagent Market by Value; 2018-2022 (US$ Billion)
Figure 19: Global Virus Detection Monoclonal Antibody Diagnostic Reagent Market by Value; 2023-2028 (US$ Billion)
Figure 20: Global Hormones Diagnosis Monoclonal Antibody Diagnostic Reagent Market by Value; 2018-2022 (US$ Billion)
Figure 21: Global Hormones Diagnosis Monoclonal Antibody Diagnostic Reagent Market by Value; 2023-2028 (US$ Billion)
Figure 22: Global Other Application Monoclonal Antibody Diagnostic Reagent Market by Value; 2018-2022 (US$ Billion)
Figure 23: Global Other Application Monoclonal Antibody Diagnostic Reagent Market by Value; 2023-2028 (US$ Billion)
Figure 24: North America Monoclonal Antibody Diagnostic Reagent Market by Value; 2018-2022 (US$ Billion)
Figure 25: North America Monoclonal Antibody Diagnostic Reagent Market by Value; 2023-2028 (US$ Billion)
Figure 26: North America Monoclonal Antibody Diagnostic Reagent Market by Region; 2022 (Percentage, %)
Figure 27: The US Monoclonal Antibody Diagnostic Reagent Market by Value; 2018-2022 (US$ Billion)
Figure 28: The US Monoclonal Antibody Diagnostic Reagent Market by Value; 2023-2028 (US$ Billion)
Figure 29: Canada Monoclonal Antibody Diagnostic Reagent Market by Value; 2018-2022 (US$ Million)
Figure 30: Canada Monoclonal Antibody Diagnostic Reagent Market by Value; 2023-2028 (US$ Million)
Figure 31: Mexico Monoclonal Antibody Diagnostic Reagent Market by Value; 2018-2022 (US$ Million)
Figure 32: Mexico Monoclonal Antibody Diagnostic Reagent Market by Value; 2023-2028 (US$ Million)
Figure 33: Europe Monoclonal Antibody Diagnostic Reagent Market by Value; 2018-2022 (US$ Billion)
Figure 34: Europe Monoclonal Antibody Diagnostic Reagent Market by Value; 2023-2028 (US$ Billion)
Figure 35: Europe Monoclonal Antibody Diagnostic Reagent Market by Region; 2022 (Percentage, %)
Figure 36: Germany Monoclonal Antibody Diagnostic Reagent Market by Value; 2018-2022 (US$ Million)
Figure 37: Germany Monoclonal Antibody Diagnostic Reagent Market by Value; 2023-2028 (US$ Million)
Figure 38: UK Monoclonal Antibody Diagnostic Reagent Market by Value; 2018-2022 (US$ Million)
Figure 39: UK Monoclonal Antibody Diagnostic Reagent Market by Value; 2023-2028 (US$ Million)
Figure 40: France Monoclonal Antibody Diagnostic Reagent Market by Value; 2018-2022 (US$ Million)
Figure 41: France Monoclonal Antibody Diagnostic Reagent Market by Value; 2023-2028 (US$ Million)
Figure 42: Italy Monoclonal Antibody Diagnostic Reagent Market by Value; 2018-2022 (US$ Million)
Figure 43: Italy Monoclonal Antibody Diagnostic Reagent Market by Value; 2023-2028 (US$ Million)
Figure 44: Spain Monoclonal Antibody Diagnostic Reagent Market by Value; 2018-2022 (US$ Million)
Figure 45: Spain Monoclonal Antibody Diagnostic Reagent Market by Value; 2023-2028 (US$ Million)
Figure 46: Rest of Europe Monoclonal Antibody Diagnostic Reagent Market by Value; 2018-2022 (US$ Million)
Figure 47: Rest of Europe Monoclonal Antibody Diagnostic Reagent Market by Value; 2023-2028 (US$ Billion)
Figure 48: Asia Pacific Monoclonal Antibody Diagnostic Reagent Market by Value; 2018-2022 (US$ Billion)
Figure 49: Asia Pacific Monoclonal Antibody Diagnostic Reagent Market by Value; 2023-2028 (US$ Billion)
Figure 50: Asia Pacific Monoclonal Antibody Diagnostic Reagent Market by Region; 2022 (Percentage, %)
Figure 51: China Monoclonal Antibody Diagnostic Reagent Market by Value; 2018-2022 (US$ Million)
Figure 52: China Monoclonal Antibody Diagnostic Reagent Market by Value; 2023-2028 (US$ Million)
Figure 53: Japan Monoclonal Antibody Diagnostic Reagent Market by Value; 2018-2022 (US$ Million)
Figure 54: Japan Monoclonal Antibody Diagnostic Reagent Market by Value; 2023-2028 (US$ Million)
Figure 55: India Monoclonal Antibody Diagnostic Reagent Market by Value; 2018-2022 (US$ Million)
Figure 56: India Monoclonal Antibody Diagnostic Reagent Market by Value; 2023-2028 (US$ Million)
Figure 57: South Korea Monoclonal Antibody Diagnostic Reagent Market by Value; 2018-2022 (US$ Million)
Figure 58: South Korea Monoclonal Antibody Diagnostic Reagent Market by Value; 2023-2028 (US$ Million)
Figure 59: Rest of Asia Pacific Monoclonal Antibody Diagnostic Reagent Market by Value; 2018-2022 (US$ Million)
Figure 60: Rest of Asia Pacific Monoclonal Antibody Diagnostic Reagent Market by Value; 2023-2028 (US$ Billion)
Figure 61: Rest of the World Monoclonal Antibody Diagnostic Reagent Market by Value; 2018-2022 (US$ Million)
Figure 62: Rest of the World Monoclonal Antibody Diagnostic Reagent Market by Value; 2023-2028 (US$ Billion)
Figure 63: The US Estimated Numbers of New Cancer Cases; 2017-2023 (Million)
Figure 64: Global Percentage of Population Aged 65 Years Or Over; 2022, 2030 & 2050 (Percentage, %)
Figure 65: Global GNI per Capita; 2016-2022 (Thousand)
Figure 66: The US Health Consumption Expenditure as a Percentage of GDP; 2016-2022 (Percentage, %)
Figure 67: Becton, Dickinson and Company Revenue by Segment; 2022 (Percentage, %)
Figure 68: Merck & Co., Inc. Sales by Segments; 2022 (Percentage, %)
Figure 69: Qiagen Net Sales by Regions; 2022 (Percentage, %)
Figure 70: Bio-Rad Laboratories, Inc. Net Sales by Segments; 2022 (Percentage, %)
Figure 71: Abcam Plc. Revenue by Regions; 2022 (Percentage, %)
Figure 72: Innovent Biologics, Inc. Revenue by Regions; 2022 (Percentage, %)
Figure 73: Celltrion, Inc. Revenue by Segments; 2022 (Percentage, %)
Table 1: Global Monoclonal Antibody Diagnostic Reagent Market Players: Financial Comparison; 2023

 

ページTOPに戻る

ご注文は、お電話またはWEBから承ります。お見積もりの作成もお気軽にご相談ください。

webからのご注文・お問合せはこちらのフォームから承ります

本レポートと同分野(バイオ薬物)の最新刊レポート

Daedal Research 社の最新刊レポート

本レポートと同じKEY WORD(antibody)の最新刊レポート


よくあるご質問


Daedal Research社はどのような調査会社ですか?


デダルリサーチ (Daedal Research) はインドとアジアを始めとして世界の医療や医薬、ICT、エネルギー、通信、化学、交通、消費財などの様々な市場を調査対象とした市場調査報告書を出版してい... もっと見る


調査レポートの納品までの日数はどの程度ですか?


在庫のあるものは速納となりますが、平均的には 3-4日と見て下さい。
但し、一部の調査レポートでは、発注を受けた段階で内容更新をして納品をする場合もあります。
発注をする前のお問合せをお願いします。


注文の手続きはどのようになっていますか?


1)お客様からの御問い合わせをいただきます。
2)見積書やサンプルの提示をいたします。
3)お客様指定、もしくは弊社の発注書をメール添付にて発送してください。
4)データリソース社からレポート発行元の調査会社へ納品手配します。
5) 調査会社からお客様へ納品されます。最近は、pdfにてのメール納品が大半です。


お支払方法の方法はどのようになっていますか?


納品と同時にデータリソース社よりお客様へ請求書(必要に応じて納品書も)を発送いたします。
お客様よりデータリソース社へ(通常は円払い)の御振り込みをお願いします。
請求書は、納品日の日付で発行しますので、翌月最終営業日までの当社指定口座への振込みをお願いします。振込み手数料は御社負担にてお願いします。
お客様の御支払い条件が60日以上の場合は御相談ください。
尚、初めてのお取引先や個人の場合、前払いをお願いすることもあります。ご了承のほど、お願いします。


データリソース社はどのような会社ですか?


当社は、世界各国の主要調査会社・レポート出版社と提携し、世界各国の市場調査レポートや技術動向レポートなどを日本国内の企業・公官庁及び教育研究機関に提供しております。
世界各国の「市場・技術・法規制などの」実情を調査・収集される時には、データリソース社にご相談ください。
お客様の御要望にあったデータや情報を抽出する為のレポート紹介や調査のアドバイスも致します。



詳細検索

このレポートへのお問合せ

03-3582-2531

電話お問合せもお気軽に

 

2024/10/11 10:26

149.62 円

164.03 円

198.16 円

ページTOPに戻る